Patents by Inventor Fabian Hulpia

Fabian Hulpia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED PHENYL-1H-PYRROLO[2,3-c] PYRIDINE DERIVATIVES
    Publication number: 20230250096
    Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compounds, and their use as menin/MLL protein/protein interaction inhibitors, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.
    Type: Application
    Filed: May 30, 2022
    Publication date: August 10, 2023
    Inventors: Wei Cai, Johannes Wilhelmus J. Thuring, Fabian Hulpia, Xuedong Dai, Ming Li, Xiangjun Deng, Chao Liang, Alicia Tee Fuay Ng, Zhen Sun, Zhigao Zhang, Samuel Dominique Demin, Natalia Nikolaevna Dyubankova, Matthiew Dominique Jouffroy, Susan Lepri, Nicolas Freddy J. Darville, Vineet Pande, Wim Bert Griet Schepens, James Patrick Edwards, Olivier Alexis Georges Querolle
  • Nucleoside analogues for the treatment of parasitic infections
    Patent number: 11072628
    Abstract: The present invention relates to novel nucleoside analogues and compositions containing said nucleoside analogues. Moreover, the present invention provides processes for the preparation of the disclosed compounds, as well as methods of using them, for instance as a medicine, in particular for the diagnosis, prevention and/or treatment of parasitic infections, more specifically for use in the diagnosis, prevention and/or treatment of a Trypanosoma infection.
    Type: Grant
    Filed: October 3, 2018
    Date of Patent: July 27, 2021
    Assignees: Universiteit Gent, Universiteit Antwerpen
    Inventors: Fabian Hulpia, Serge Van Calenbergh, Guy Caljon, Louis Maes
  • NUCLEOSIDE ANALOGUES FOR THE TREATMENT OF PARASITIC INFECTIONS
    Publication number: 20210024566
    Abstract: The present invention relates to novel nucleoside analogues and compositions containing said nucleoside analogues. Moreover, the present invention provides processes for the preparation of the disclosed compounds, as well as methods of using them, for instance as a medicine, in particular for the diagnosis, prevention and/or treatment of parasitic infections, more specifically for use in the diagnosis, prevention and/or treatment of a Trypanosoma infection.
    Type: Application
    Filed: October 3, 2018
    Publication date: January 28, 2021
    Inventors: Fabian Hulpia, Serge Van Calenbergh, Guy Caljon, Louis Maes